Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice
- 1 February 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (4) , 535-539
- https://doi.org/10.1016/0006-2952(82)90156-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Purine metabolism in Leishmania donovani and Leishmania braziliensisBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Analysis of Adenosine and Other Adenine Compounds in Patients With Immunodeficiency DiseasesJournal of Liquid Chromatography, 1978
- A ROLE FOR PURINE METABOLISM IN THE IMMUNE RESPONSE: ADENOSINE-DEAMINASE ACTIVITY AND DEOXYADENOSINE CATABOLISMThe Lancet, 1978
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- Purine metabolism in adenosine deaminase deficiency.Proceedings of the National Academy of Sciences, 1976
- The adenosine‐like effect of exogenous cyclic AMP upon nucleotide and PP‐ribose‐P concentrations of cultured human lymphoblastsFEBS Letters, 1976
- Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.Journal of Clinical Investigation, 1976
- Adenosine Inhibition of Lymphocyte-Mediated Cytolysis: Possible Role of Cyclic Adenosine MonophosphateScience, 1975
- Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adeninesJournal of Medicinal Chemistry, 1974